Bruno Achutti Duso Selected Research

Protein-Tyrosine Kinases (Tyrosine Kinase)

10/2013

Locoregional recurrence in patients with HER2 positive breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bruno Achutti Duso Research Topics

Disease

8	Neoplasms (Cancer) 01/2024 - 10/2013
2	Breast Neoplasms (Breast Cancer) 02/2018 - 10/2013
1	Leukemia 01/2024
1	Mesothelioma 12/2020
1	COVID-19 01/2020
1	Carcinogenesis 01/2019

Drug/Important Bio-Agent (IBA)

2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2019
1	InterferonsIBA 01/2024
1	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2024
1	Insulin (Novolin)FDA Link 12/2020
1	GoldIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2019
1	CTLA-4 AntigenIBA 01/2019
1	B7-H1 AntigenIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	ChemokinesIBA 04/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2018
1	EnzymesIBA 04/2018
1	ribociclibIBA 02/2018
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2013
1	Trastuzumab (Herceptin)FDA Link 10/2013
1	ErbB Receptors (EGF Receptor)IBA 10/2013

Therapy/Procedure

4	Therapeutics 01/2019 - 05/2017
3	Precision Medicine 01/2019 - 01/2019
1	Caloric Restriction 01/2024
1	Postoperative Care 05/2017
1	Critical Care (Surgical Intensive Care) 05/2017
1	Radiotherapy 10/2013